Alternative approaches to target Myc for cancer treatment

C Wang, J Zhang, J Yin, Y Gan, S Xu, Y Gu… - Signal transduction and …, 2021 - nature.com
The Myc proto-oncogene family consists of three members, C-MYC, MYCN, and MYCL,
which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc …

Target gene-independent functions of MYC oncoproteins

A Baluapuri, E Wolf, M Eilers - Nature Reviews Molecular Cell Biology, 2020 - nature.com
Oncoproteins of the MYC family are major drivers of human tumorigenesis. Since a large
body of evidence indicates that MYC proteins are transcription factors, studying their function …

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

C Dubiella, BJ Pinch, K Koikawa, D Zaidman… - Nature chemical …, 2021 - nature.com
The peptidyl-prolyl isomerase, Pin1, is exploited in cancer to activate oncogenes and
inactivate tumor suppressors. However, despite considerable efforts, Pin1 has remained an …

Mission possible: advances in MYC therapeutic targeting in cancer

BL Allen-Petersen, RC Sears - BioDrugs, 2019 - Springer
MYC is a master transcriptional regulator that controls almost all cellular processes. Over the
last several decades, researchers have strived to define the context-dependent …

Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor

M Welcker, B Wang, DV Rusnac, Y Hussaini… - Science …, 2022 - science.org
c-Myc (hereafter, Myc) is a cancer driver whose abundance is regulated by the SCFFbw7
ubiquitin ligase and proteasomal degradation. Fbw7 binds to a phosphorylated Myc degron …

Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153

YN Li, CW Chen, T Trinh-Minh, H Zhu, AE Matei… - Bone research, 2022 - nature.com
Bone mass is maintained by the balance between osteoclast-induced bone resorption and
osteoblast-triggered bone formation. In inflammatory arthritis such as rheumatoid arthritis …

Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability

Z Luo, D Xin, Y Liao, K Berry, S Ogurek, F Zhang… - Nature …, 2023 - nature.com
MYC-driven medulloblastomas are highly aggressive childhood brain tumors, however, the
molecular and genetic events triggering MYC amplification and malignant transformation …

Nucleoporin 153 links nuclear pore complex to chromatin architecture by mediating CTCF and cohesin binding

S Kadota, J Ou, Y Shi, JT Lee, J Sun… - Nature …, 2020 - nature.com
Nucleoporin proteins (Nups) have been proposed to mediate spatial and temporal
chromatin organization during gene regulation. Nevertheless, the molecular mechanisms in …

Therapeutic targets for endothelial dysfunction in vascular diseases

DTN Huynh, KS Heo - Archives of Pharmacal Research, 2019 - Springer
Vascular endothelial cells are located on the surface of the blood vessels. It has been
recognized as an important barrier to the regulation of vascular homeostasis by regulating …

WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating

BA Scholz, N Sumida, CDM de Lima, I Chachoua… - Nature …, 2019 - nature.com
WNT signaling activates MYC expression in cancer cells. Here we report that this involves
an oncogenic super-enhancer-mediated tethering of active MYC alleles to nuclear pores to …